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Cerebrovascular disease is an exciting subject, so 
complex that we could devote 30 minutes to a dis-
cussion of aspirin, dipyridamole, and sulfinpyra-
zone and their potential actions in the prevention of 
thromboembolic events. A Classification and Outline 
of Cerebrovascular Disease II , published in the Sep-
tem her-October 1975 issue of Stroke, depicts this 
complexity. The portion labeled "outline" describes 
some of the things summarized in this paper. 
The first part of the Classification is labeled 
"Clinical Stage"; it is where we make contact with 
most patients, including even those with asymptom-
atic bruit. The "Clinical Stage" is subdivided into 
"Transient lschemic Attacks," "Progressing Stroke," 
and "Completed Stroke." TIA is the abbreviation for 
transient focal cerebral ischemic attacks. It has be-
come popular. in the United Kingdom to refer to 
syncope as a TIA; elsewhere in the world, however, 
the word "focal" must be included in the term tran-
sient cerebral ischeniic attack; thus syncope is not 
listed urider "Transient lschemic Attacks." TI As are 
important because they are warnings of a serious or 
progressing or devastating stroke to come . They have 
certain significant characteristics: the onset is rapid 
(defined as no symptoms to maximal symptoms in 
less than two minutes) ; the duration commonly is 2 
to 30 minutes. In an attempt to establish a standard, 
we state in the Stroke dassification that a TIA can 
last as long as 24 hours . Seldom ; however, does a TIA 
last 24 hours ; most of us believe that someone who 
has a focal cerebrovascular event which lasts 20 
hours probably has a small infarct. An attack which 
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lasts two to five or ten minutes, as in amaurosis 
fugax, has not in that instance produced retinal is-
chemia to the point of retinal infarction. The same 
theory applies to the brain; an attack of short dura-
tion does not produce cerebral infarction. The resolu-
tion or disappearance of each episode is swift; the 
frequency of attacks is variable. Significantly, the 
diagnosis is almost always made on the basis of the 
history , particularly in office practice. Over 25 years I 
have witnessed only a few attacks. Frequently I am 
asked, "Did you really complete the study and prove 
the diagnosis by doing an arteriogram?" An arteri-
ogram will not reveal whether a patient has had a 
TIA or not; it will only display detail concerning the 
morphology of the vessels. Anatomically, TIAs are 
subdivided into two categories; carotid and vertebro-
basilar. With the development of surgical reconstruc-
tion for lesions in the carotid system, there is every 
reason for making the clinical distinction between 
these two symptoms. 
The typical history for a TIA in the carotid [arterial] 
system is ... : 
I . Motor defect (weakness, paralysis, poor use, or 
clumsiness of one extremity or of both extremities on the 
same side). 
2. Sensory defect (numbness including loss of sen-
sat ion or paresthesias involving one or both exremities 
on the same side). 
3. Aphasia (speech and/or language disturbance 
which may be only a minor defect or may be global and 
may or may not include difficulty in reading , writing, or 
performing calculations). 
4. Loss of vision in one eye or in part of one eye 
when vision in both eyes was intact (amaurosis fugax). 
5. Homonymous hemianopia. 
6. Combinations of the above. 
These clinical phenomena generally represent a de-
crease or absence of function. When there is a sensory 
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event, it is commonly described as coming on all a t once, 
that is , without a march . 
The typical history for a TIA in the vertebrobasilar 
arterial system is .. 
I . Motor defect (weakness, clumsiness, or paralysis 
of any combination of extremities up to quadriplegia, 
sometimes changing from one side to another in differ-
ent attacks). 
2. Sensory defect (numbness, including loss of sen-
sation or paresthesias in any combination of extremities 
including all four or involving both sides of the face or 
mouth. This is frequently bilateral trouble or the distribu-
tion may change from side to side in different attacks). 
3. Loss of vision, complete or partial in both ho-
monymous fields (bilateral homonymous hemianopia) . 
4. Homonymoµs hemianopia. 
5. Ataxia, imbalance, unsteadiness, or dysequilibrium 
not associated witli vertigo. 
6. Either vertigo (with or without nausea and vomit-
ing), diplopia, dysphagia , or dysarthria is not to be con-
sidered as a TIA when any of these symptoms occurs 
alone, but in combination with one another or with any 
of the above (numb6rs I, 2, 3 and 4) the attacks should be 
considered a TIA. 
7. Combinations of the above. 
These clinical phenomena generally represent a de-
crease or absence of function. At times, the motor, sen-
sory , or visual defect constituting the content of a verte-
brobasilar attack will be unilateral. It becomes difficult 
in such instances to make a distinction between whether 
the locus of ischemia is in the carotid arterial system or in 
the vertebrobasilar arterial system . In the list above, 
"drop attacks" is omitted. Fainting (syncope) is fre-
quently confused with a " drop attack," so the latter 
shou ld be included in the vertebrobasilar profile only 
when the patient's description of the "drop attack" is 
absolutely clear. The variety of manifestations included 
in the vertebrobasilar profile makes the potential pat-
tern of symptoms considerably more variable and com-
plex than that in the carotid system. 
The diagnosis of TIA rests on the history of the at-
tacks; the skill with which the history is taken and the 
interpretation of the history , except for those relatively 
few instances where the physician is with the patient at 
the time of the attack. The criteria for making the diag-
nosis will vary depending on whether an individual 
physician is working with an individual patient or 
whether the purpose is the screening of a population for 
TIAs. A problem is created, as in much of medical diag-
nosis , because of the relative weight or significance of 
some historical phoriomena compared to other phenom-
ena. The symptom "numbness" (mentioned above) is 
an example. If the question is, "Have you ever had a 
numb hand0 , " the answer from most adults will be "yes." 
This question is almost completely non-selective (non-
diagnostic) and must be followed by a series of questions 
to estab lish the meaning and significance of the "numb-
ness. " In contrast , another phenomenon, when present , 
is simple and relatively much more significant than 
"numbness;" i.e. , "Have you ever had painless blindness 
in one eye which came on very quickly (seconds) and 
lasted only a few minutes (5 to 20)?" is a question 
which , if answered "yes," is reasonably specific. Another 
similar but less specific question is " Have you ever had 
the sudden onset of a 5 to 20-minute duration attack of 
severe weakness of one side of the body (arm and leg)?" 
Another is "Have you ever suddenly lost the ability to 
speak (5 to 20 minutes' duration) or to understand the 
speech of others?" These questions illustrate the impor-
tance of understanding that different questions may have 
relatively different cqmplexity and importance. 
The matter of relative significance of different sym-
toms is important in the vertebrobasilar system as it is in 
the carotid system. For instance, if one asks the question , 
"Have you ever had any dizziness" ," almost all adults 
will answer "yes." This question is almost completely 
non-selective (non-diagnostic) and if answered affirma-
tively must be followed by a series of direct and branch-
ing questions to e?tablish the meaning and signific;mce 
of the original phenomenon-"dizziness." A diagnosis of 
a TIA in the vert~brobas ilar system should not be made 
on the basis of a history of a few minµtes of vertigo as the 
on ly symptom. This is emphasized since vertigo is the 
most common symptom in the vertebrobasilar system; 
however, a diagnosis of vertebrobasilar TIA is made only 
when there is concurrently with vertigo (dizziness) an ad-
ditional symptom or symptoms. 
In some instances, patients with carotid system 
TIAs may ha ve physical signs of appropriate arterial 
disease. These include diminished pulsation in the carotid 
artery , a bruit over the carotid artery or eye, emboli in 
the retinal vessels, or other signs of ischemic retinopathy 
and relative hypotension in the retinal artery as measured 
with the ophthalmodynamometer. These are only signs 
of arterial disease and may be present in the absence of 
a history of TIAs. In certain instances , bruits signifying 
compromise of flow in the innominate artery, either 
subclavian artery, or at the origin of ei ther ve rtebral 
artery may be present ; however, th e a bsence or presence 
of such sounds does not weigh heavily in the diagnosis of 
vertebrobasilar TIA since it is again emphasized that 
the diagnosis is dependent upon the history of the at-
tack , not upqn morphological evidence of change in 
patterns of blood flow . 
Certain symptoms may appear in a TIA in either 
arterial system. The most important of these are: 
I. Dysarthri~, if it occurs alone, and 
2. Homonymous hemianopia , if it occurs alone. 
The occurrence of certain symptoms in solitary 
fashion constitutes an attack which is an "uncertain 
TIA. " An attack which cons ists so lel y of each of the fol-
lowing symptoms should be categorized as an unce rtain 
TIA: 
I . Vertigo a lone 
2 . Dysarthria a lone 
3. Dysphagia alone 
4. Diplopia alone 
For the sake 9f clarity, the following symptoms, 
transient or prolonged, are not to be included as TIA: 
I. Unconsciousness including syncope 
2. Tonic and/ or clonic activity 
3. March of a sensory defect 
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4. Vertigo alone 
5. Dysphagia alone 
6. Dysarthria alone 
7. Incontinence of bowel or bladder 
8. Dizziness or wooziness a lone 
9. Loss of vision associated wi th alteration of con-
sciousness 
10. Focal symptoms associated with migraine 
11. Scintillating scotomata 
12. Confusion alone 
13. Amnesia alone 
The different ial diagnosis of TIAs includes "hemi-
plegic" migraine, focal convulsive events (often due to 
neoplasm and producing either sensory or motor 
phenomena), Meniere' s disorder, sensory phenomena 
associated with hyperventilation, and finally some un-
known mechanism. The differentiation of "hemiplegic" 
migraine is a semantic a nd practical problem. In those in-
stances where the aura of migraine is associated with a 
definitely focal neurological event, the latter may well 
be the result of transient focal cerebral ischemia but the 
implications are different than the usual TIA. To es-
tablish a diagnosis of the migraine association, there 
is ordinarily a positive family history, characteristic uni-
lateral headache with nausea and sometimes vomiting, 
and onset of the attacks several decades ahe~d of the age 
at which T!As commonly begin. Very careful history-
taking ordinarily delineates the transient focal events 
associated with brain neoplasm from T!As and this is 
also true of the other items in the differential diagnosis.' 
It is necessary to understand the pathogenesis of 
the attacks to treat them properly. Strokes occur in 
people who have atherosclerosis; common sites are in 
the cervical arteries and in the circle of Willis and its 
main branches. Strokes do not occur in patients free 
of atherosclerosis unless there is a distal occlusion by 
an embolus from the heart or other site. Cerebral 
infarcts are statistically associated with ather()-
sclerosis. How does a static atherosclerotic lesion 
in the neck produce the sudden onset, in a matter of 
seconds, of a hemiparesis which lasts for five minutes 
and disappears leaving the person normal? How of-
ten does cerebral atherosclerosis occur without caus-
ing symptoms? In 100 consecutive autopsies of 
patients 50 years of age or older, the arch of the 
aorta, all cervical vessels, vessels at the base of the 
brain , and the brain were studied. Under the term 
"stenosis," only a lumen narrowed 50% or more was 
counted. There were 77 cervical stenoses in 28 
patients. Of these 28 people, 18 had never had any 
symptoms of nervous system trouble of any kind . 
There were 15 cervical occlusions in 12 people. Six of 
these 12 had never had any symptoms of nervous 
system trouble. There were 40 people ( 40%) of 
the I 00 who had cervical atherosclerosis, not count-
ing intracranial lesions . Sixty percent of these pa-
tients were without any symptoms of nervous sys-
tem trouble. This same observation has been made 
concerning coronary atherosclerosis. Many people 
with coronary atherosclerosis have neither angina 
nor a myocardial infarction . It is apparent that some 
factor, in addition to atherosclerosis, has to be present 
to produce the sudden onset and short duration of 
the attacks . In 1955, I postulated that atherosclero-
sis plus one or more of the following could cause 
an attack: tra,nsient systemic hypotension, poly-
cythemia, kinking or external compression, shunting, 
transient hypoglycemia, vasospasm, severe anemia, 
thrombosis or embolism or both. The transient sys-
temic hypotension theory was in vogue over a decade 
ago. The notion was that if there were distal stenosis 
of an artery and the perfusion pressure dropped , 
there would be a disproportionate decrease in per-
fusion distal to the stenosis, thereby causing ischemia 
for the duration of that decreased perfusion pressure, 
and ischemia in the territory supplied by that vessel. 
The physician should search for cardiac causes of 
transient systemic hypotension even though this is an 
uncommon cause of TIA. At the Mayo Clinic, only 
1.4% of 290 consecutive patients being implanted 
with cardiac pacemakers had had focal transient neu-
rological phenomena. In most instances there were 
episodes of diffuse cerebral ischemia (syncope). Poly-
cythemia is found in I% or 2% of our TIA patients, 
whether vertebra-basilar or carotid. Polycythemia 
should be appropriately studied and treated. Reversal 
of flow in a vertebral artery because of occlusion or 
stenosis of a subclavian artery has been called "sub-
clavian steal." It can be diagnosed in the office as 
there is a decrease in brachial blood pressure on the 
side involved, a radial pulse lag, and a decrease in the 
palpable pulse pressure on that side. The symptom 
complex associated with this, certainly in our institu-
tion, has never been defined and operations for this 
defect are seldom performed . 
The items of greatest importance in the patho-
genesis of TIA appear to be thrombosis and embo-
lism . Cholesterol and fibrin-platelet emboli have been 
observed in the retina; streamlining of flow explains 
the similarities between the neurological content of a 
patient's attacks while fragmentation of emboli or 
lysis of thrombosis is a plausible explanation for the 
short duration of episodes. The appearance of choles-
terol emboli in the retina means that there is an 
ulcerated carotid lesion on that side. 
The natural history of TIA has received consid-
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erable study. Are TIAs warning events? Twelve re-
ports are summarized in the following table (Table 
I ). 
The one study with a result different from the 
others is Marshall's. 9 A few months later, Marshall 13 
published an entirely different result ; 43% of TIA 
patients had cerebral infarction when followed for 
60 months. In Marshall's first report it appears that 
many of the patients had a complaint of occasional 
dizziness and were not having focal cerebral transient 
ischemic attacks. In the study by Pearce et al,5 the 
duration of follow-up was only 10.6 months which 
is too short a time to discover the true natural history 
of TIA . 
One is often asked about the indications for cra-
nial arteriography. These are: 
I. Differential diagnosis of the brain pathology. 
Even with careful attention to all the items listed 
under history, general examination, neurological ex-
am ination , neurovascular examination, and addi-
tional tests, there still remain about 5% of patients 
whose diagnosis is uncertain. Computerized tomog-
raphy (EMI, ACTA, DELTA scanners, and others) 
is revolutionizing the differential diagnosis of in-
tracranial lesions. In a few instances, cervical-cere-
bral angiography is the best method for distin-
guishing between vascular occlusive disease , an 
intracerebral expanding mass such as hemorrhage, 
abscess or brain tumor, cerebral infarction, and sub-
dural hematoma, as well as demonstrating aneurysms 
and arteriovenous malformations. 
2. Transient focal ischemic attacks, particu larly 
in the carotid system. Cervical-cerebral angiography 
should be performed if one or more of these condi-
tions is evident: amaurosis fugax, bruit over the be-
ginning of the internal carotid artery, retinal emboli, 
unilateral decrease in retinal artery pressure, or is-
chemic retinopathy. If none of these is present, the 
likelihood of finding a lesion accessib le to the surgeon 
is small. 
3. Selected instances of vertebra-basilar TIAs. 
It may be difficult to make a clinical distinction be-
tween the carotid and the vertebra-basilar system. If 
the TIAs are characteristic of those coming from the 
vertebra-basi lar system, there is little need for exten-
sive angiography . 
4. Early progressing stroke or frequent TIAs in 
the carotid system with evidence of amaurosis, an 
appropriate bruit, retinal emboli, or other conditions. 
5. Many patients with subarachnoid hemor-
rhage and some patients with intracerebral hemor-
rhage . 
A less certain indication for cranial arteri-
ography is a loud, long systo lic or systolic-diastolic 
internal carotid artery bruit in patients scheduled for 
major general surgery. If there is prolonged hypoten-
sion or very severe blood loss , the carotid stenosis 
may decrease blood supply to a focal region of the 
brain to a critical level of ischemia . Recent observa-
tions suggest that such patients do not have an in-
creased risk of stroke; therefore, arteriography is not 
necessa ry. 
Table I 
STUDY 
Sieker! et al' 
Cooperative' 
Fisher' 
Pearce et a I' 
Baker et al' 
Baker et al' 
Friedman et al' 
Marshall' 
Ziegler and Hassanein" 
Goldner* et al" 
Whisnant et al 12 
Marshall 13 
Twelve Reports Summarizing Natural History of TIAs as Warning Events 
N UMBER OF FOLLOW-UP 
PATIENTS (Mos.) 
160 60 
20 20 
23 
20 10.6 
30 40.6 
79 41 
23 27.4 
61 45 
135 36 
140 180 av •1 
Ill av? 
198 60 
158 60 
NORMAL 
83 (52%) 
11 (55%) 
54 (89%) 
CEREBRAL INFARCT 
TOTAL 
51 (32%) 
5 (25%) 
8(34%) 
2( 10%) 
7 (23%) 
17 (22%) 
8 (35%) 
I (2%) 
22 (16%) 
43 (38%) 
62 (32%) 
68 (43%) 
LETHAL 
18( 11 %) 
I (5%) 
0 
0 
I (2%) 
5 (3.7%) 
27 (24%) 
C EREBRA!. 
H EMORRI-IAGE 
7(4%) 
0 
0 
I (2%) SAH 
* Goldner, Whisnant and Taylor reported concerning 140 TIA patients followed for 15 years. The table gives occurrence of stroke 
in 111 patients. 
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Recalling the thrombosis-embolism mechanism, 
it is apparent that there are several ways to treat 
TIAs; one of these is the administration of an oral 
anticoagu lant. Table 2 shows the data in six reports 
in which a direct attempt has been made to compare 
untreated patients su ffering from transient ischemic 
attacks with those receiving a nticoagulant drugs. 
Anticoagu lants should not be used if: I). the 
physician is unfamiliar with the drugs, 2) the patient 
is not fully cooperative, or 3) laboratory results are of 
uncertain quality. The actual number of patients in 
five of the studies in Table 2 is so small as to make 
comparison between the treated and untreated 
groups invalid. Nevertheless, the percentage of in-
d ividuals with cerebral infarction was similar in 
all of the treated groups of each study. The effective-
ness of concurrent treatment of arterial hypertension, 
in decreasing the frequency of intracerebral hemor-
rhage, cannot be assessed in these studies; it seems 
reasonable that the danger may be less now that 
a ntihypertensive therapy is better developed. It is 
apparent that anticoagulant therapy decreases the 
risk of cerebral infarction in patients with transient 
ischemic attacks . However, other types of treatment 
should be considered including thromboendarter-
ectomy and the administration of an tiplatelet ag-
glutinating agents. 
Although thousands of operations on the carotid 
artery have been performed since the report by East-
colt, Pickering and Rob 14 in 1954, knowledge con-
cerning the effects of surgery to prevent subsequent 
cerebra l infarction in patients with T IA is still lim-
ited. In the Joint Study of Extracranial Arteria l Oc-
clusion V, 15 the collaborating in vestigators reported 
that 316 patients had transient ischemic attacks; 169 
received surgical treatment and 14 7 received medical 
treatment. The follow-up period averaged 42 months. 
In the surgically t reated gro up, 15% of the patients 
suffered cerebral in farct ion (including postoperative 
complications) while 14% of the medically treated 
subjects had cerebral infarction. The best results were 
noted in a subgroup of 94 patients having transient 
ischemic attacks and unilateral carotid stenosis; 45 
underwent surgery and 49 were treated medica lly. Six 
percent of the su rgica lly treated patients had cerebral 
infarctio n during the tota l course o f the study com-
pared with 12% of the med ically treated group. Bauer 
et a l,16 a lso reporting for the Joint Study of Extra-
cranial Arterial Occlusion, noticed statistically signif-
icant differences in the cumulative survival rates at 42 
months a nd reported that: 
(I) surgical treatment appeared more beneficia l for 
uni lateral carot id stenosis in patients with transient 
ischemic attacks or a mild to moderate neurological 
TABLE 2 
Six Studies Comparing Untreated TIA Patients with Those Receiving Anticoagulant Therapy 
NUMBER OF 
STUDY PATIENTS 
Sieker! el al' 
Control 160 
Treated 175 
Cooperative Study' 
Control 20 
Treated 24 
Fisher' 
Control 23 
Treated 29 
Pearce et a l' 
Control 20 
Treated 17 
Baker et al' 
Control 30 
Treated 30 
Friedman et a l' 
Control 23 
Treated 2 1 
FOLLOW-UP 
(Mos.) 
60 
60 
20 
18 
30 
10.6 
II.I 
40.6 
37.9 
27.4 
27.4 
NORMAL 
83 (52%) 
131 (75%) 
11 (55%) 
7 (4 1%) 
* Three treated patients randomly chosen had CY A after A/ C stopped. 
I One cerebral hemorrhage in treated group but while off anticoagulant. 
CEREBRAL INFARCT 
TOTAL LETHAL 
51 (32%) 18 ( 11 %) 
7(4%) 3(2%) 
5 (25%) I (5%) 
I (4%) 0 
8(34%) 0 
I (3%) 0 
2 (10%) 
I (5%) 
7* (23%) 
2 
8• 0 
0 0 
' One patient had been on A/ C, but A/ C was discontinued before the cerebral infarction. 
CE REBRAi. 
H EMO RRIIAGF 
7 (4%) 
13 (7%) 
0 
2 (8%) 
0 
0 
o, 
I (4%) SAH 
0 
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deficit, (2) nonsurgical treatment produced better results 
for unilateral carotid stenosis in patients with a moderate 
to severe neurological deficit, (3) nonsurgical treatment 
appeared more beneficial for combined unilateral 
protid artery stenosis and contralateral carotid artery 
occlusion o f patients who had a moderate to severe 
neurological deficit, and (4) nonsurgical treatment ap-
peared more beneficial for patients with completed 
strokes who had a marked and persistent neurological 
deficit. 
It is apparent from the many reports in the liter-
ature that physicians clinically active in the cerebro-
vascular field are moderately to greatly enthusiastic 
about surgical treatment for carotid system TIA 
when an appropriate carotid lesion is discovered. Un-
fortunately, no long-term follow-up of a precisely 
studied group of surgically treated carotid TIA 
patients is available, but it seems likely that results 
have improved since the report by the Joint Study of 
Extracranial Arterial Occlusion . 
In the last decade, aspirin, dipyridamole (Per-
santine®) and sulfinpyrazone (Anturane®) have been 
investigated in the laboratory and in some human 
clinical settings because of their effect on blood plate-
let aggregability or adhesiveness or both. A direct 
relationship between these characteristics of platelets 
and the pathogenesis of transient ischemic attacks 
has not yet been firmly established. Dyken et a l17 de-
scribed 26 patients, in a retrospective study, of whom 
15 were treated with aspirin (300 mg b.i .d.) and 11 
were not. No difference was noted in the incidence of 
cerebral infarction or death in the two groups, but 
only two ( 13%) of those receiving aspirin had an ad-
ditional TIA while nine (82%) of those receiving no 
aspirin had subsequent TIA . The author stressed that 
this study did not prove the effectiveness of aspirin, 
but that it pointed to the need for a prospective in-
vestigation of the subject. 
Two cooperative studies of platelet aggregating 
agents' effect on transient ischemic attacks are under-
way, one in Canada and one in the United States. 
Formal comprehensive reports from these studies are 
not yet available. Atthe Tenth Princeton Conference 
on Cerebral Vascular Disease in 1976, Fields18 gave a 
brief overview of some of the experience in the 
United States Cooperative Study of aspirin for the 
treatment of transient focal cerebral ischemic attacks. 
He reported that in patients hav ing one attack, there 
was no difference between treated and untreated 
patients, but that in patients having multiple TIAs, 
those receiving aspirin appeared to have a better "re-
sult." This Cooperative Study has been discontinued. 
Barnett'" (Canadian Cooperative Study) was asked 
about the results of his investigation which involved 
comparisons between several treatments (aspirin, sul-
finpyrazone, and other drugs). He commented that 
the statistics to date had been carefully reviewed and 
that the results appeared to be inconclusive. There 
was no reason to stop the investigation and every 
reason to continue it. At this time, the pressing ques-
tions concerning the effectiveness of these agents re-
main unanswered . 
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